RNASE3 and asthma: These concentrations were much greater than those for the remaining 390 MPP patients without complications from secondary asthma (IgE, 13.76 ± 0.75 μg/L, P < 0.01; ECP, 143.5 ± 25.35 IU/mL, P < 0.01) (Figure 3).